Open Collections

UBC Faculty Research and Publications

Pharmaceutical innovation : can health and economic goals be met? Morgan, Steve; Mochrie, Clare

Abstract

Canadians spend hundreds of millions of dollars per year on pharmaceutical research and development (R&D) through governments, charitable organizations,and private investment. While the pharmaceutical industry accounts for only 2% of the Canadian economy, it is responsible for more than 10% of all Canadian R&D; and although research in other sectors has decreased in recent years, pharmaceutical R&D continues to rise. From a public policy perspective, the hope is that this R&D will spur pharmaceutical innovation with benefits to population health and the economy. The degree to which these goals are both being realized, however, is the subject of increasing debate. This paper investigates the drivers of pharmaceutical R&D and re-examines how “innovations” from this sector are defined and promoted. Our aim is to reframe these issues and stimulate a new, balanced debate on pharmaceutical innovation.

Item Metadata

Title
Pharmaceutical innovation : can health and economic goals be met?
Creator
Morgan, Steve; Mochrie, Clare
Contributor
University of British Columbia. Centre for Health Services and Policy Research
Publisher
Centre for Health Services and Policy Research (CHSPR)
Date Issued
2008-07
Description
Canadians spend hundreds of millions of dollars per year on pharmaceutical research and development (R&D) through governments, charitable organizations,and private investment. While the pharmaceutical industry accounts for only 2% of the Canadian economy, it is responsible for more than 10% of all Canadian R&D; and although research in other sectors has decreased in recent years, pharmaceutical R&D continues to rise. From a public policy perspective, the hope is that this R&D will spur pharmaceutical innovation with benefits to population health and the economy. The degree to which these goals are both being realized, however, is the subject of increasing debate. This paper investigates the drivers of pharmaceutical R&D and re-examines how “innovations” from this sector are defined and promoted. Our aim is to reframe these issues and stimulate a new, balanced debate on pharmaceutical innovation.
Subject
Drug development -- Canada; Pharmaceutical policy -- Canada; Pharmaceutical industry -- Canada; Research -- economics -- Canada; Health Policy -- Canada; Drug Industry -- Canada
Geographic Location
Canada
Genre
Report
Type
Text
Language
eng
Date Available
2014-08-26
Provider
Vancouver : University of British Columbia Library
Rights
Attribution-NonCommercial-NoDerivs 2.5 Canada
DOI
10.14288/1.0048420
URI
http://hdl.handle.net/2429/50227
Affiliation
Medicine, Faculty of; Population and Public Health (SPPH), School of
Peer Review Status
Unreviewed
Scholarly Level
Faculty; Researcher
Rights URI
http://creativecommons.org/licenses/by-nc-nd/2.5/ca/
Aggregated Source Repository
DSpace

Item Media

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivs 2.5 Canada